Canopy Growth (TSE:WEED – Get Free Report) had its price target decreased by investment analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research note issued on Monday,BayStreet.CA reports. The firm currently has a “sell” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential downside of 46.81% from the company’s current price.
Separately, ATB Capital downgraded Canopy Growth from a “sector perform” rating to an “underperform” rating and cut their price objective for the company from C$6.00 to C$4.00 in a research report on Tuesday, December 17th. Four analysts have rated the stock with a sell rating and one has issued a hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of C$5.40.
Read Our Latest Report on WEED
Canopy Growth Price Performance
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Merck: 4 No-Brainer Reasons to Buy This Dip
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Are Treasury Bonds?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.